Pre-surgical risk stratification based on PDE4D7 expression and pre-surgical clinical variables
AssigneeKoninklijke Philips N.V.
InventorRalf Dieter Hoffmann
Life of this patent
Estimating the term…
Loading patent…
AssigneeKoninklijke Philips N.V.
InventorRalf Dieter Hoffmann
Estimating the term…
The invention relates to a method of pre-surgical risk stratification of a prostate cancer subject, comprising determining a gene expression profile for phosphodiesterase 4D variant 7 (PDE4D7) in a biological sample obtained from the subject, determining gene expression profile, and determining a pre-surgical prognostic risk score for the subject based on the expression based risk score and pre-surgical clinical variables of the subject. This may allow for an improved stratification of the subject in a pre-surgical setting that may result in better primary treatment decisions. For instance, the pre-surgical prognostic risk score may allow to make better recommendation on whether to select active surveillance vs. active intervention, e.g., radical prostatectomy, for certain sub-populations of prostate cancer patients.
A method of risk stratification of a prostate cancer subject, comprising:
Use of a gene expression profile for phosphodiesterase 4D variant 7 (PDE4D7) in risk stratification of a prostate cancer subject, comprising:
Dependencies are inferred from the claim text.